Your browser doesn't support javascript.
loading
The economic burden of fragile x syndrome: healthcare resource utilization in the United States.
Sacco, Patricia; Capkun-Niggli, Gorana; Zhang, Xin; Jose, Rosemary.
  • Sacco P; Director of Global Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Capkun-Niggli G; Director of Global Health Economics and Outcomes Research, Novartis Pharma AG, Basel, Switzerland.
  • Zhang X; Statistical Analyst, Beijing Novartis Pharma Co, Ltd, Shanghai, China.
  • Jose R; Evidence Analyst, Global Health Economics and Outcomes Research, Novartis Healthcare Private Limited, Hyderabad, India.
Am Health Drug Benefits ; 6(2): 73-83, 2013 Mar.
Article en En | MEDLINE | ID: mdl-24991348
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Año: 2013 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Año: 2013 Tipo del documento: Article